ARC welcomed Jan Griffin, MD, amyloidosis cardiologist at the Medical University of South Carolina. Dr. Griffin discussed how ATTR affects the heart and explored advances in treatments for ATTR-CM.
She explained the medications currently available, how they work, how doctors know if they’re helping, and what new treatments are coming in the future.
The webinar concluded with a Q&A session.
Original Presentation Date: